Loading clinical trials...

Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients | Clinical Trials | Clareo Health

COMPLETED

Procalcitonin Level as a Surrogate for Catheter-related Blood Stream Bacteremia Among Hemodialysis Patients

NCT03039777•Benha University

View on ClinicalTrials.gov

Summary

Hemodialysis patients frequently develop catheter-related blood stream bacteremia (CRBSI). Procalcitonin is a marker of sepsis in bacterial infection. this study for detection of its role as a surrogacy marker in CRBSI.

Detailed Description

Catheter-related blood stream bacteremia is common among hemodialysis patients. Clinically, fever and/or rigors with laboratory indicator of inflammation as leucocytosis and elevated c-reactive protein level are considered as markers for CRBSI before blood culture results became available. Procalcitonin is a valid indicator of sepsis. In this study, Procalcitonin level will be measured in any patient with suspected CRBSI and correlation will be tested for proved CRBSI by blood cultures.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Hemodialysis patients with a dialysis catheter
•signs suggestive of CRBSI: fever/chills or leucocytosis with no other site of infection.
•Informed consent signed to be enrolled in the study

Exclusion Criteria

•Patient with identified cause of fever other than CRBSI

Locations (1)

New jeddah clinic Hospital

Jeddah, Saudi Arabia

Key Dates

Start Date

September 1, 2016

Primary Completion Date

February 28, 2017

Completion Date

March 1, 2017

Last Updated

July 17, 2017

Enrollment

ACTUAL participants

Conditions

Hemodialysis Catheter Infection

Pharmacokinetics Study of Cefazolin in Hemodialysis (CEFAZODIAL)

NCT06093269

Hemodialysis Catheter InfectionInfection, Bacterial

View study

COMPLETEDNA

Chlorhexidine Dressings for Hemodialysis Catheter Exit Site Care: Comparative Study

NCT05855616

Hemodialysis Catheter Infection

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 17, 2017Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions